5-131431122-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016340.6(RAPGEF6):c.4202C>T(p.Ala1401Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016340.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAPGEF6 | NM_016340.6 | c.4202C>T | p.Ala1401Val | missense_variant | 26/28 | ENST00000509018.6 | NP_057424.3 | |
RAPGEF6 | NM_001164386.2 | c.4226C>T | p.Ala1409Val | missense_variant | 27/29 | NP_001157858.1 | ||
RAPGEF6 | NM_001164387.2 | c.4241C>T | p.Ala1414Val | missense_variant | 28/29 | NP_001157859.1 | ||
RAPGEF6 | NM_001164388.2 | c.4226C>T | p.Ala1409Val | missense_variant | 27/28 | NP_001157860.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAPGEF6 | ENST00000509018.6 | c.4202C>T | p.Ala1401Val | missense_variant | 26/28 | 1 | NM_016340.6 | ENSP00000421684.1 | ||
ENSG00000273217 | ENST00000514667.1 | c.4352C>T | p.Ala1451Val | missense_variant | 27/29 | 2 | ENSP00000426948.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | The c.4226C>T (p.A1409V) alteration is located in exon 27 (coding exon 27) of the RAPGEF6 gene. This alteration results from a C to T substitution at nucleotide position 4226, causing the alanine (A) at amino acid position 1409 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.